COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.

Published on Jul 1, 2020in Neuroimmunology and Neuroinflammation7.724
· DOI :10.1212/NXI.0000000000000753
Mahdi Barzegar8
Estimated H-index: 8
(IUMS: Isfahan University of Medical Sciences),
Omid Mirmosayyeb12
Estimated H-index: 12
(IUMS: Isfahan University of Medical Sciences)
+ 4 AuthorsVahid Shaygannejad25
Estimated H-index: 25
(IUMS: Isfahan University of Medical Sciences)
In December 2019, a novel coronavirus causing an infectious respiratory disease (COVID-19) was identified, which since then has developed into a pandemic with higher rates of mortality in older individuals and those with underlying medical conditions.1 Multiple sclerosis (MS) is an immune-mediated neurologic disease which requires long-term treatment with immunotherapies that have been shown to increase the risk of infections.2 As a result, there is significant anxiety among patients and neurologists during the pandemic regarding the infection outcome in this patient population. We present a patient with MS treated with fingolimod who was diagnosed with COVID-19 and had a favorable outcome.
📖 Papers frequently viewed together
202079.32The Lancet
29 Authors (Yeming Wang, Li Zhang)
13 Authors (Ling Mao, ..., Bo Hu)
#1Gavin Giovannoni (QMUL: Queen Mary University of London)H-Index: 107
#2Christopher Hawkes (QMUL: Queen Mary University of London)H-Index: 123
Last. Julian Gold (QMUL: Queen Mary University of London)H-Index: 27
view all 6 authors...
#1Wei-jie Guan (Guangzhou Medical University)H-Index: 27
#3Y Y Hu (Guangzhou Medical University)H-Index: 13
Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of...
#1Adam Bernheim (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 14
#2Xueyan Mei (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 7
Last. Michael H. Chung (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 26
view all 14 authors...
Abstract In this retrospective study, chest CTs of 121 symptomatic patients infected with coronavirus disease-19 (COVID-19) from four centers in China from January 18, 2020 to February 2, 2020 were...
#1Gustavo Luna (KI: Karolinska Institutet)H-Index: 1
#2Peter Alping (KI: Karolinska Institutet)H-Index: 5
Last. Thomas Frisell (KI: Karolinska Institutet)H-Index: 29
view all 16 authors...
Importance Although highly effective disease-modifying therapies for multiple sclerosis (MS) have been associated with an increased risk of infections vs injectable therapies interferon beta and glatiramer acetate (GA), the magnitude of potential risk increase is not well established in real-world populations. Even less is known about infection risk associated with rituximab, which is extensively used off-label to treat MS in Sweden. Objective To examine the risk of serious infections associated...
#1Brian Barry (GUMC: Georgetown University Medical Center)H-Index: 1
#2April ErwinH-Index: 3
Last. Carlo Tornatore (GUMC: Georgetown University Medical Center)H-Index: 6
view all 4 authors...
Because the treatment of multiple sclerosis (MS) may span decades, the need often arises to make changes to the treatment plan in order to accommodate changing circumstances. Switching drugs, or the discontinuation of immunomodulatory agents altogether, may leave patients vulnerable to relapse or disease progression. In some cases, severe MS disease activity is noted clinically and on MRI after treatment withdrawal. When this disease activity is disproportionate to the pattern observed prior to ...
#1Giovanni NoviH-Index: 14
#3Matteo Pizzorno (University of Milan)H-Index: 5
Last. Antonio UccelliH-Index: 66
view all 8 authors...
#1Andrew J. Steelman (UIUC: University of Illinois at Urbana–Champaign)H-Index: 16
Over the past several decades, significant advances have been made in identifying key factors that contribute to the pathogenesis of multiple sclerosis (MS) and have culminated in the approval of some effective therapeutic strategies for disease intervention. However, the mechanisms by which environmental factors, such as infection, contribute to the pathogenesis and/or symptom exacerbation remain to be fully elucidated. Relapse frequency in MS patients contributes to neurological impairment and...
Cited By51
#1Saad KhanH-Index: 2
#2Kayla F. GoliwasH-Index: 5
Last. Jessy DeshaneH-Index: 39
view all 3 authors...
#1Varsha TiwariH-Index: 7
#2Manish Kumar (Maharishi Markandeshwar University, Mullana)H-Index: 71
Last. Renu Saharan (Maharishi Markandeshwar University, Mullana)H-Index: 1
view all 7 authors...
Coronaviruses are terrifically precise and adapted towards specialized respiratory epithelial cells, observed in organ culture and human volunteers both. This virus is found to possess an unpredictable anti-viral T-cell response which in turn results in T-cell activation and finally apoptosis, leading to cytokine storm and collapse of the whole immune system. The present review provides comprehensive information regarding SARS-CoV-2 infection, mutant strains, and the impact of SARS-COV-2 on vita...
#1Tobias Zrzavy (Medical University of Vienna)H-Index: 11
#2Isabella Wimmer (Medical University of Vienna)H-Index: 15
Last. Thomas Berger (Medical University of Vienna)H-Index: 10
view all 4 authors...
The outbreak of the SARS-CoV-2 pandemic with an until then unknown, infectious agent posed unprecedented challenges to health care systems and unmasked their vulnerability and limitations worldwide. Patients with long-term immunomodulatory/suppressive therapies, as well as their physicians, were and are concerned about balancing the risk of infection and disease-modifying effects. Over the last few months, the knowledge regarding SARS-CoV-2 has been growing tremendously, as well as the first exp...
The COVID-19 pandemic was announced in 2020, and many professional medical societies had to review their algorithms for the management of high-risk patients. In addition to risk factors such as overweight, age over 65 years, cardiovascular disease, diabetes mellitus, and bronchial asthma, other chronic diseases should also be emphasized, taking into account possible immunosuppressive therapy. This publication presents two clinical cases of COVID-19 infection in patients with multiple sclerosis t...
#1Verónica CabreiraH-Index: 4
#2Pedro AbreuH-Index: 9
Last. Maria José SáH-Index: 22
view all 5 authors...
Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine response dynamics. A systematic review on COVID-19 course and outcomes in patients receiving different DMTs was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Emerging data on SARS-CoV-2 vaccines was used to elaborate recommendations. Data from 4417 patients sugges...
#1Georgina Arrambide (Autonomous University of Barcelona)H-Index: 22
Last. Mayra Gómez-MorenoH-Index: 2
view all 40 authors...
Objective null To understand COVID-19 characteristics in people with multiple sclerosis (MS) and identify high-risk individuals due to their immunocompromised state resulting from the use of disease-modifying treatments. null Methods null Retrospective and multicenter registry in patients with MS with suspected or confirmed COVID-19 diagnosis and available disease course (mild = ambulatory; severe = hospitalization; and critical = intensive care unit/death). Cases were analyzed for associations ...
#1Medha Karnik (Jagadguru Sri Shivarathreeswara University)H-Index: 2
#2Narasimha M Beeraka (MSMU: I.M. Sechenov First Moscow State Medical University)H-Index: 8
Last. SubbaRao V. Madhunapantula (Jagadguru Sri Shivarathreeswara University)H-Index: 24
view all 7 authors...
Coronavirus disease 2019 (COVID-19) is a devastating viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The incidence and mortality of COVID-19 patients have been increasing at an alarming rate. The mortality is much higher in older individuals, especially the ones suffering from respiratory distress, cardiac abnormalities, renal diseases, diabetes, and hypertension. Existing evidence demonstrated that SARS-CoV-2 makes its entry into human cells through angio...
#1Vittorio ManteroH-Index: 10
#2Lucia AbateH-Index: 8
Last. Christian Cordano (UCSF: University of California, San Francisco)H-Index: 13
view all 7 authors...
#1Vittorio ManteroH-Index: 10
#2Damiano BaronciniH-Index: 12
Last. Christian Cordano (UCSF: University of California, San Francisco)H-Index: 13
view all 9 authors...
#1Andrea M Kuczynski (U of T: University of Toronto)
#2Jiwon Oh (U of T: University of Toronto)H-Index: 28
Multiple sclerosis (MS) is an inflammatory disease that causes chronic neurological disability in young adults. Modulation of sphingosine 1-phosphate (S1P) receptors, a group of receptors that, among other things, regulate egression of lymphocytes from lymph nodes, has proven to be effective in treating relapsing MS. Fingolimod, the first oral S1P receptor modulator, has demonstrated potent efficacy and tolerability, but can cause undesirable side effects due to its interaction with a wide range...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.